Tags

Type your tag names separated by a space and hit enter

Policy statement on folic acid and neural tube defects.
Genet Med 2011; 13(6):593-6GM

Abstract

It now recognized that the use of folate fortification and/or supplementation before initiation of pregnancy can impact the risk of the fetus developing a neural tube defect. This document serves to update the policy statement issued by the American College of Medical Genetics and published in 2005.

Authors+Show Affiliations

Spectrum Health Hospitals and College of Medicine, Michigan State University, Grand Rapids, Michigan 49503, USA. helga.toriello@spectrum-health.orgNo affiliation info available

Pub Type(s)

Journal Article
Practice Guideline

Language

eng

PubMed ID

21552133

Citation

Toriello, Helga V., and Policy and Practice Guideline Committee of the American College of Medical Genetics. "Policy Statement On Folic Acid and Neural Tube Defects." Genetics in Medicine : Official Journal of the American College of Medical Genetics, vol. 13, no. 6, 2011, pp. 593-6.
Toriello HV, Policy and Practice Guideline Committee of the American College of Medical Genetics. Policy statement on folic acid and neural tube defects. Genet Med. 2011;13(6):593-6.
Toriello, H. V. (2011). Policy statement on folic acid and neural tube defects. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 13(6), pp. 593-6. doi:10.1097/GIM.0b013e31821d4188.
Toriello HV, Policy and Practice Guideline Committee of the American College of Medical Genetics. Policy Statement On Folic Acid and Neural Tube Defects. Genet Med. 2011;13(6):593-6. PubMed PMID: 21552133.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Policy statement on folic acid and neural tube defects. AU - Toriello,Helga V, AU - ,, PY - 2011/5/10/entrez PY - 2011/5/10/pubmed PY - 2011/9/29/medline SP - 593 EP - 6 JF - Genetics in medicine : official journal of the American College of Medical Genetics JO - Genet. Med. VL - 13 IS - 6 N2 - It now recognized that the use of folate fortification and/or supplementation before initiation of pregnancy can impact the risk of the fetus developing a neural tube defect. This document serves to update the policy statement issued by the American College of Medical Genetics and published in 2005. SN - 1530-0366 UR - https://www.unboundmedicine.com/medline/citation/21552133/Policy_statement_on_folic_acid_and_neural_tube_defects_ L2 - http://dx.doi.org/10.1097/GIM.0b013e31821d4188 DB - PRIME DP - Unbound Medicine ER -